Diagnosis and Treatment of Spontaneous Bacterial Peritonitis (SBP)
The diagnosis of SBP is established with an ascitic fluid polymorphonuclear (PMN) leukocyte count >250/mm³, and treatment should be initiated immediately with a third-generation cephalosporin plus albumin infusion to reduce mortality. 1, 2
Diagnostic Criteria
When to Perform Diagnostic Paracentesis
- Diagnostic paracentesis should be performed in all patients with cirrhosis and ascites at hospital admission, even without symptoms suggestive of infection 1
- Additional indications for paracentesis include:
Diagnostic Confirmation
- SBP diagnosis is confirmed with an ascitic fluid PMN count >250/mm³ 1, 2
- Ascitic fluid should be cultured at bedside in aerobic and anaerobic blood culture bottles before starting antibiotics 1
- Blood cultures should also be obtained before initiating antibiotics to increase the chance of isolating the causative organism 1
- Bedside inoculation of at least 10 mL of ascitic fluid into blood culture bottles increases culture sensitivity to >90% 1
Special Diagnostic Considerations
- Bacterascites: PMN count <250/mm³ with positive ascitic fluid culture 1
- Spontaneous bacterial pleural empyema: Consider in patients with pleural effusion 1
- Diagnosis based on pleural fluid with positive culture and PMN >250/mm³ OR negative culture with PMN >500/mm³ 1
- Secondary bacterial peritonitis: Must be differentiated from SBP 1
Treatment Recommendations
Empirical Antibiotic Therapy
- Initiate empirical antibiotics immediately after diagnosis, without waiting for culture results 1, 2
- First-line treatment: Third-generation cephalosporins 1, 2
- Alternative options:
- Avoid potentially nephrotoxic antibiotics (e.g., aminoglycosides) 1
Albumin Therapy
- Intravenous albumin should be administered at 1.5 g/kg at diagnosis and 1 g/kg on day 3 2
- Albumin significantly reduces the risk of hepatorenal syndrome and mortality 2
Monitoring Response
- Perform repeat paracentesis after 48 hours of treatment 2
- Treatment failure is defined as:
- If treatment fails, consider:
Evolving Microbiology Patterns
- Traditionally, gram-negative bacteria (especially E. coli and Klebsiella) were most common (60%) 1, 3
- Recent shift toward gram-positive bacteria and multidrug-resistant organisms (MDROs), particularly in nosocomial and healthcare-associated SBP 1, 4
- MDROs represent approximately 35% of infections in cirrhotic patients 1
- This shift has led to decreased response to standard empirical antibiotics 1
Prognosis
- SBP has approximately 20% hospital mortality rate despite infection resolution 2
- Early appropriate antibiotic treatment combined with albumin therapy significantly improves survival 2
Common Pitfalls and Caveats
- Delaying antibiotic therapy increases mortality - in cirrhotic patients with septic shock, mortality increases by 10% for every hour's delay in initiating antibiotics 1
- Up to one-third of patients with SBP may be entirely asymptomatic or present with only encephalopathy and/or acute kidney injury 1, 5
- Ascitic fluid culture is frequently negative even when performed in blood culture bottles, but is important for guiding antibiotic therapy 1, 6
- Consider secondary bacterial peritonitis in patients with inadequate response to therapy or polymicrobial cultures 1, 5